samedan logo
home > pmps

Pharmaceutical Manufacturing and Packing Sourcer


Pharmaceutical Manufacturing and Packing Sourcer (PMPS) is a specialist journal designed to provide worldwide coverage of a range of topics relating to the pharmaceutical manufacturing and packaging sector.

Published quarterly, the journal functions as a platform of communication and information-sharing for executive and strategic decision makers within the industry, identifying new trends and marketing opportunities, as well as highlighting the latest innovations in this dynamic environment. PMPS is specifically designed to interest those in the pharma, biotech, nutritional, and medical device industries who are actively seeking to source services for improved efficiency in what is an increasingly competitive market 

For further information please contact:

Simon Caplan

Joseph O'Connor

We're also on Twitter! Follow us @PMPSmag  



Click here to view the digital version of PMPS



Click here to view the digital version of the Parenteral Technology Supplement


Featured in this issue
Parenteral Technology Supplement
Adopting Connected Drug Delivery Devices

George I’ons at Owen Mumford Pharmaceutical Services

Against the backdrop of an ageing population and a rise in non-communicable diseases, digitally transforming the healthcare system is essential. Even before the current world health crisis, healthcare systems were feeling the strain due to increasing demand, which was placing more pressure on resources. If patient self-management and teleconsultations are not systematically developed and expanded, hard-pressed health services around the world will struggle to withstand the pressure.
Parenteral Technology Supplement
Choosing the Right Packaging

Cecilia Bassi at Bormioli Pharma

Packaging is a critical factor of success for parenteral medicine. In fact, packaging and drug formulation actually must go along in terms of development, and choosing the right container for a drug is all but an easy task. This is true in the pharmaceutical industry in general and, above all, when it comes to parenteral drugs.

Parenteral dosage forms differ from all other drugs because they are injected directly into the tissue through the primary protective systems of the human body, such as skin and mucous membranes.
  Packaging Potent Products
The Trend Towards Continuous Improvement

Fabian Stöcker at SCHOTT

Fabian Stöcker: I think there has been a lot of innovation, particularly in the last five to seven years. One major trend in packaging is that it was previously offered in what we would call a ‘bulk format’, this means the packaging was not washed or pre-sterilised. Now, we are seeing improvements in the supply chain.


Published quarterly in
February, May,
August, and November


Industry Events

World Vaccine Congress Washington

27-29 September 2020, Walter E Washington Convention Center, Washington, US

The World Vaccine Congress is an award-winning series of conferences and exhibitions that have grown to become the largest and most established vaccine meeting of its kind across the globe. Our credibility is show through the prestigious scientific advisory board that spend months of hard work creating a new and topical agenda, year on year.
More info >>

News and Press Releases

Vetter further expands its Development Service with new site in Austria

CDMO addressing growing customer demand Investment in additional clinical filling options in Europe Planned ‘go live’ in 2021 Ravensburg, Germany and Rankweil, Austria, July 8, 2020 – With biopharmaceutical development heavily focused on specialized therapeutics, drug sponsors are increasingly turning to expert outsourcing partners to meet growing demand for complex fill and finish solutions. Vetter, a leading global Contract Development and Manufacturing Organization (CDMO) is further investing in additional capacity to meet that growing global demand with the purchase of a clinical manufacturing site located in Austria.
More info >>

White Papers

The Impact of Components on Drug Quality and Risk Mitigation

West Pharmaceutical Services, Inc.

Expectations for quality by regulatory agencies are increasing at a very fast pace, especially for prefilled drug delivery formats, thanks to increased focus on reducing risk to patient safety. The trend has resulted in delays for new drug applications, more recalls of marketed products and even drug shortages if the container system and drug contents are suspect for quality issues. The pharmaceutical market is now requiring manufacturers of containers and components to meet new expectations with a quality culture and very high product reliability. The need to bridge the gap and provide superior quality products has been a driver for manufacturing technology investments, more robust control strategies and the introduction of next generation elastomer components.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement